- Home
- VELO vs BRNS Comparison
VELO vs BRNS Comparison
Compare VELO & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VELO
- BRNS
- Stock Information
- Founded
- VELO 2014
- BRNS 2016
- Country
- VELO United States
- BRNS United Kingdom
- Employees
- VELO N/A
- BRNS N/A
- Industry
- VELO Industrial Machinery/Components
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- VELO Technology
- BRNS Health Care
- Exchange
- VELO Nasdaq
- BRNS Nasdaq
- Market Cap
- VELO 63.7M
- BRNS 55.9M
- IPO Year
- VELO N/A
- BRNS 2021
- Fundamental
- Price
- VELO $5.48
- BRNS $1.33
- Analyst Decision
- VELO Strong Buy
- BRNS Strong Buy
- Analyst Count
- VELO 1
- BRNS 1
- Target Price
- VELO $6.00
- BRNS $3.00
- AVG Volume (30 Days)
- VELO 1.2M
- BRNS 79.4K
- Earning Date
- VELO 11-26-2025
- BRNS 11-06-2025
- Dividend Yield
- VELO N/A
- BRNS N/A
- EPS Growth
- VELO N/A
- BRNS N/A
- EPS
- VELO N/A
- BRNS N/A
- Revenue
- VELO $43,765,000.00
- BRNS $14,969,000.00
- Revenue This Year
- VELO $30.60
- BRNS N/A
- Revenue Next Year
- VELO $57.71
- BRNS N/A
- P/E Ratio
- VELO N/A
- BRNS N/A
- Revenue Growth
- VELO N/A
- BRNS 1766.46
- 52 Week Low
- VELO $1.43
- BRNS $0.64
- 52 Week High
- VELO $29.25
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- VELO N/A
- BRNS 50.39
- Support Level
- VELO N/A
- BRNS $1.20
- Resistance Level
- VELO N/A
- BRNS $1.38
- Average True Range (ATR)
- VELO 0.00
- BRNS 0.12
- MACD
- VELO 0.00
- BRNS -0.02
- Stochastic Oscillator
- VELO 0.00
- BRNS 42.62
About VELO Velo3D Inc. Common stock
Velo3D Inc provides additive manufacturing (AM), also referred to as three-dimensional printing (3D printing), to deliver breakthroughs in performance, cost, and time in the production of high-value metal parts. The Velo3D intelligent metal additive manufacturing solution is comprised of the Velo3D Flow intelligent print preparation software, the Sapphire production system, and Velo3D Assure, real-time quality assurance software. Its complete manufacturing solution enables clients to build the parts needed, speed their development, and reduce their product costs.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.